Access the full text.
Sign up today, get DeepDyve free for 14 days.
S.G. Inge-Vechtomov (2000)
Yeast Prions and the Central Dogma of Molecular BiologyVestn. Ross. Akad. Nauk, 70
K. Doh-Ura, T. Kitamoto, Y. Sakaki, J. Tateishi (1991)
CJD DiscrepancyNature, 358
B. Jeong, J. Nam, Yun-Jung Lee, Kyung-Hee Lee, M. Jang, R. Carp, H. Lee, Y. Ju, S. Jo, Keun-Yong Park, Yong-Sun Kim (2004)
Polymorphisms of the prion protein gene (PRNP) in a Korean populationJournal of Human Genetics, 49
M. Soldevila, F. Calafell, A. Andrés, J. Yagüe, Agnar Helgason, K. Stefánsson, J. Bertranpetit (2003)
Prion susceptibility and protective alleles exhibit marked geographic differencesHuman Mutation, 22
Piero Parchi, S. Capellari, S. Chin, H. Schwarz, N. Schecter, J. Butts, P. Hudkins, D. Burns, J. Powers, P. Gambetti (1999)
A subtype of sporadic prion disease mimicking fatal familial insomniaNeurology, 52
L.A. Zhivotovsky (1991)
Populyatsionnaya biometriya
A. Plaitakis, Anna Viskadouraki, M. Tzagournissakis, I. Zaganas, S. Verghese-Nikolakaki, Vasilis Karagiorgis, Ioannis Panagiotides, Constantine Kilindireas, E. Patsouris, C. Haberler, H. Budka, T. Sklaviadis (2001)
Increased incidence of sporadic Creutzfeldt‐Jakob disease on the island of Crete associated with a high rate of PRNP 129‐methionine homozygosity in the local populationAnnals of Neurology, 50
Stephanie Grubenbecher, O. Stüve, H. Hefter, C. Korth (2006)
Prion protein gene codon 129 modulates clinical course of neurological Wilson diseaseNeuroReport, 17
J. Brandel, M. Preece, P. Brown, E. Croes, J. Laplanche, Y. Agid, R. Will, A. Alpérovitch (2003)
Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UKThe Lancet, 362
Xiaohong Li, L. Rowland, H. Mitsumoto, S. Przedborski, T. Bird, G. Schellenberg, E. Peskind, N. Johnson, T. Siddique, M. Mesulam, S. Weintraub, J. Mastrianni (2005)
Prion protein codon 129 genotype prevalence is altered in primary progressive aphasiaAnnals of Neurology, 58
(1994)
Iatrogenic Creutzfeldt‐Jakob disease An example of the interplay between ancient genes and modern medicine
K. Zimmermann, P. Turecek, H. Schwarz (1999)
Genotyping of the prion protein gene at codon 129Acta Neuropathologica, 97
S. Prusiner (1998)
Nobel Lecture: PrionsProceedings of the National Academy of Sciences of the United States of America, 95
T. Sørensen, R. Ransohoff (1998)
Etiology and pathogenesis of multiple sclerosis.Seminars in neurology, 18 3
J. Laplanche, N. Delasnerie-Laupretre, J. Brandel (1994)
Molecular Genetics of Prion Diseases in France: French Research Group on Epidemiology of Human Spongiform EncephalopathiesNeurology, 44
E. Croes, B. Alizadeh, A. Bertoli-Avella, Tessa Rademaker, J. Vergeer-Drop, B. Dermaut, J. Houwing-Duistermaat, D. Wientjens, A. Hofman, C. Broeckhoven, C. Duijn (2004)
Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt–Jakob diseaseEuropean Journal of Human Genetics, 12
A. Alpérovitch, I. Zerr, M. Pocchiari, E. Mitrová, J. Cuesta, I. Hegyi, S. Collins, H. Kretzschmar, C. Dujin, R. Will (1999)
Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob diseaseThe Lancet, 353
J. Bratosiewicz, P. Liberski, J. Kulczycki, R. Kordek (2001)
Codon 129 polymorphism of the PRNP gene in normal Polish population and in Creutzfeldt-Jakob disease, and the search for new mutations in PRNP gene.Acta neurobiologiae experimentalis, 61 3
A. Tahiri‐Alaoui, A. Gill, P. Disterer, W. James (2004)
Methionine 129 Variant of Human Prion Protein Oligomerizes More Rapidly than the Valine 129 VariantJournal of Biological Chemistry, 279
J. Deslys, D. Marcé, D. Dormont (1994)
Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease.The Journal of general virology, 75 ( Pt 1)
Zuev Va (2001)
From prion diseases to the problem of aging and deathVestnik Rossiĭskoĭ akademii meditsinskikh nauk / Rossiĭskaia akademiia meditsinskikh nauk
N. Erginel-Unaltuna, K. Peoc’h, Evrim Komurcu, Tufan Acuner, H. Issever, J. Laplanche (2001)
Distribution of the M129V polymorphism of the prion protein gene in a Turkish population suggests a high risk for Creutzfeldt-Jakob diseaseEuropean Journal of Human Genetics, 9
I.A. Zavalishin, M.N. Zakharova, T.D. Zhuchenko, A.V. Peresedova (2000)
Rasseyannyi skleroz: Izbrannye voprosy teorii i praktiki
T. Wells (2006)
Multiple Sclerosis Genes Step out of the Shadows, Business Briefing: Future Drug Discovery
J. Laplanche, N. Delasnerie‐Lauprêtre, J. Brandel, J. Chatelain, P. Beaudry, A. Alpérovitch, J. Launay (1994)
Molecular genetics of prion diseases in FranceNeurology, 44
B. Dermaut, E. Croes, R. Rademakers, M. Broeck, M. Cruts, A. Hofman, C. Duijn, C. Broeckhoven (2003)
PRNP Val129 homozygosity increases risk for early‐onset Alzheimer's diseaseAnnals of Neurology, 53
M. Nurmi, M. Bishop, L. Strain, F. Brett, C. McGuigan, M. Hutchison, Michael Farrell, R. Tilvis, S. Erkkilä, O. Simell, R. Knight, M. Haltia (2003)
The normal population distribution of PRNP codon 129 polymorphismActa Neurologica Scandinavica, 108
E. Croes, B. Dermaut, Jeanine Houwing‐Duistermaat, M. Broeck, M. Cruts, M. Breteler, A. Hofman, C. Broeckhoven, C. Duijn (2003)
Early cognitive decline is associated with prion protein codon 129 polymorphismAnnals of Neurology, 54
M. Soldevila, A. Andrés, A. Ramírez-Soriano (2008)
worldwide resequencing study The prion protein gene in humans revisited: Lessons from a
M. Palmer, Aidan Dryden, J. Hughes, J. Collinge (1991)
Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob diseaseNature, 352
G. Georgsson, T. Tryggvason, Á. Jónasdóttir, S. Gudmundsson, S. Thorgeirsdóttir (2006)
Polymorphism of PRNP codons in the normal Icelandic populationActa Neurologica Scandinavica, 113
J. Bland, D. Altman (2000)
The odds ratioBMJ : British Medical Journal, 320
Claudine Berr, Florence Richard, C. Dufouil, Carole Amant, A. Alpérovitch, P. Amouyel (1998)
Polymorphism of the prion protein is associated with cognitive impairment in the elderlyNeurology, 51
M. Riemenschneider, N. Klopp, W. Xiang, S. Wagenpfeil, C. Vollmert, U. Müller, Hans Förstl, T. Illig, H. Kretzschmar, A. Kurz (2004)
Prion protein codon 129 polymorphism and risk of Alzheimer diseaseNeurology, 63
C. Newton, A. Graham, L. Heptinstall, S. Powell, C. Summers, N. Kalsheker, J. Smith, A. Markham (1989)
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).Nucleic acids research, 17 7
C. Berr, F. Richard, C. Dufouil (1998)
Polymorphism of the Prion Protein is Associated with Cognitive Impairment in the Elderly: The EVA StudyNeurology, 51
E. Mitrová, V. Mayer, V. Jovankovicová, D. Slivarichová, L. Wsólová (2005)
Creutzfeldt–Jakob disease risk and PRNP codon 129 polymorphism: necessity to revalue current dataEuropean Journal of Neurology, 12
Inyoul Lee, D. Westaway, A. Smit, Kai Wang, Jason Seto, Lei Chen, Chetana Acharya, Mike Ankener, Dale Baskin, Carol Cooper, Hong Yao, S. Prusiner, Leroy Hood (1998)
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species.Genome research, 8 10
W. Mcdonald, A. Compston, G. Edan, D. Goodkin, H. Hartung, F. Lublin, H. McFarland, D. Paty, C. Polman, S. Reingold, M. Sandberg-wollheim, W. Sibley, A. Thompson, S. Noort, B. Weinshenker, J. Wolinsky (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 50
D. Rujescu, A. Hartmann, C. Gonnermann, H. Möller, I. Giegling (2003)
M129V variation in the prion protein may influence cognitive performanceMolecular Psychiatry, 8
S. Wójtowicz (1993)
Multiple sclerosis and prions.Medical hypotheses, 40 1
M. Soldevila, A. Andrés, A. Ramírez-Soriano, Tomàs Marquès-Bonet, F. Calafell, A. Navarro, J. Bertranpetit (2005)
The prion protein gene in humans revisited: lessons from a worldwide resequencing study.Genome research, 16 2
B. Jeong, J. Nam, K. Lee (2004)
Polymorphisms of the Prion Gene (PRNP) in a Korean PopulationJ. Hum. Genet., 49
R. Bo, M. Scarlato, S. Ghezzi, F. Martinelli-Boneschi, C. Fenoglio, G. Galimberti, S. Galbiati, R. Virgilio, D. Galimberti, C. Ferrarese, E. Scarpini, N. Bresolin, G. Comi (2006)
Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysisNeurobiology of Aging, 27
S. Pruisiner (1998)
PrionsProc. Natl. Acad. Sci. USA, 95
J. Collinge, M. Palmer, Aidan Dryden (1991)
Genetic predisposition to iatrogenic Creutzfeldt-Jakob diseaseThe Lancet, 337
M. Tsai, Y. Su, Y-H Chen, C.-H. Chen (2001)
Lack of evidence to support the association of the human prion gene with schizophreniaMolecular Psychiatry, 6
Sonja Scholz, G. Xiromerisiou, H. Fung, J. Eerola, O. Hellström, A. Papadimitriou, G. Hadjigeorgiou, P. Tienari, H. Fernandez, R. Mandel, M. Okun, Katharina Gwinn-Hardy, A. Singleton (2006)
The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct populationsNeuroscience Letters, 395
M. Salvatore, M. Genuardi, R. Petraroli, C. Masullo, M. D’Alessandro, M. Pocchiari (1994)
Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob diseaseHuman Genetics, 94
J. Deslys, D. Marce, D. Dormont (1994)
Similar Genetic Susceptibility in Iatrogenic and Creutzfeldt-Jakob DiseaseJ. Gen. Virol., 75
O. Combarros, M. Sánchez-Guerra, J. Llorca, A. Alvarez-Arcaya, J. Berciano, N. Peña, C. Fernández-Viadero (2000)
Polymorphism at codon 129 of the prion protein gene is not associated with sporadic ADNeurology, 55
M129V polymorphism of prion protein gene PRNP has been studied in patients with multiple sclerosis (MS) and healthy ethnic Russians from Bashkortostan using allele-specific PCR. The genotype frequency distribution of the examined polymorphism in Russians from Bashkortostan was similar to that in European populations. MM, MV, and VV genotype frequencies in control group and in the MS patients were 50.24%, 42.58%, 7.18% and 43.33%, 45.83%, 10.84%, respectively. It was shown that in the group of MS patients with onset of the disease at the age of 21 and older, the frequency of the VV genotype was higher than in the control group (14.3% versus 6.18%, respectively, P = 0.041). We suggest that the VV genotype is associated with higher risk factor of MS development in the patients aged 21 years and older.
Russian Journal of Genetics – Springer Journals
Published: May 17, 2009
Access the full text.
Sign up today, get DeepDyve free for 14 days.